ONC · BeOne Medicines Ltd ADR
United States · RS rating 74 · As of 2026-11-03
| Price | 355.00 USD |
|---|---|
| 1-day change | -1.7% |
| RS rating (overall / 1M / 3M / 12M) | 74 / 52 / 80 / 63 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 39 / 43 / 45 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -50.0% |
| Sales growth Q/Q | +6.1% |
| Distance from 52-week high | +8.1% |
| Market cap (USD) | $33.3B |